Patrizia Giannatempo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
Journal: Expert opinion on biological therapy
Published: August 29, 2026
How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 14, 2026
177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.
Journal: Expert review of anticancer therapy
Published: May 06, 2026
Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced Bladder Cancer-A Podcast.
Journal: Advances in therapy
Published: April 15, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.
Journal: Frontiers in immunology
Published: February 26, 2026
The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study.
Journal: The oncologist
Published: February 08, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series.
Journal: Minerva urology and nephrology
Published: January 27, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
Journal: Clinical genitourinary cancer
Published: January 14, 2026
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.
Journal: British journal of cancer
Published: November 01, 2025
MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials.
Journal: European urology oncology
Published: October 21, 2025
Last Updated: 09/26/2026